Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
477.37
+5.37 (+1.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
51
52
Next >
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
The meeting went almost as well as could be expected.
Via
The Motley Fool
Vertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and Exposition
November 02, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Exploring NASDAQ:VRTX's quality characteristics.
October 30, 2023
Reasonable Growth, Debt Levels, and a High ROIC Make VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Appealing to Quality Investors.
Via
Chartmill
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
October 20, 2023
Via
Benzinga
Vertex to Present Data Highlighting Long-Term Benefits of TRIKAFTA® at the North American Cystic Fibrosis Conference
November 02, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
This stock could be a long-term winner, thanks to its game-changing technology.
Via
The Motley Fool
Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
November 01, 2023
Via
Benzinga
Crispr Therapeutics Rallies On Bullish Views Of First-Ever Gene-Editing Drug
November 01, 2023
The agency could soon approve a potential cure for sickle cell disease .
Via
Investor's Business Daily
Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90
October 31, 2023
Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.
Via
The Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
October 28, 2023
4x returns in just a decade is quite an attainable result for these companies.
Via
The Motley Fool
CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy
October 27, 2023
Although CRISPR Therapeutics may have a breakthrough drug on its hands, regulatory concerns hang over CRSP stock.
Via
InvestorPlace
Exposures
Product Safety
Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher
October 27, 2023
A Relative Strength Rating upgrade for Rocket Pharmaceuticals shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches
October 27, 2023
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next
Via
Benzinga
Exposures
Product Safety
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
October 27, 2023
These companies come from very different industries, but each has businesses that investors may find compelling.
Via
The Motley Fool
IBD's 100 Best ESG Companies For 2023
October 27, 2023
The companies on our list combine high sustainability scores and top stock ratings.
Via
Investor's Business Daily
2 Healthcare Stocks That Could Make You Richer
October 27, 2023
The need for healthcare is consistent and ongoing, a reality that makes this industry resilient to economic downturns.
Via
The Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
October 26, 2023
These companies are building out their revenue and profit streams, and the proof is in the pudding.
Via
The Motley Fool
This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024
October 26, 2023
This rare disease company is on a roll.
Via
The Motley Fool
2 Best Healthcare Stocks to Buy Right Now
October 26, 2023
The healthcare industry is an explosive space full of promising, profitable companies.
Via
The Motley Fool
Vertex to Present at Upcoming Investor Conferences
October 26, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals: Buy at the High?
October 26, 2023
Vertex shares have been flying high in recent times.
Via
The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
October 26, 2023
Great healthcare businesses are out there and their stocks are ripe for the picking.
Via
The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
October 26, 2023
These businesses are thriving and raking in profits.
Via
The Motley Fool
2 Fantastic Growth Stocks to Buy Hand Over Fist
October 26, 2023
These stocks make great bargains today.
Via
The Motley Fool
3 Red-Hot Growth Stocks That Are Still Cheap Buys
October 25, 2023
It's not too late to invest in these great businesses.
Via
The Motley Fool
Apellis Pharmaceuticals Stock Shows Rising Relative Strength
October 24, 2023
A Relative Strength Rating upgrade for Apellis Pharmaceuticals shows improving technical performance. Will it continue?
Via
Investor's Business Daily
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
Today, the following three healthcare players look like fantastic bargains.
Via
The Motley Fool
3 Unstoppable Stocks to Buy Sooner Rather Than Later
October 22, 2023
Now is the time to invest in these great stocks.
Via
The Motley Fool
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.